Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Q4 2022 Earnings Call Transcript

It gives you real time revenue growth but it also makes it sustainable by increasing the weighted average market growth of the company. The second is investment in the commercial channel. You’ve got to have the commercial channel and capability to drive that innovation and make it real. The third is portfolio–active portfolio management, really looking at moving things into the organization and out of the organization that can drive our weighted average market growth rate up, so we are clearly in that phase. We have a better balance sheet right now that we’re going to be able to leverage in that part of the transformation, and make no mistake, we feel very confident about Phase 1, Phase 2, and now Phase 3 given that balance sheet freedom that we’re going to have going forward.

With that, I think we’ll go ahead and end the call.

Keri Mattox: Yes, thanks everyone for joining us. I’m sure we’ll talk today, and of course if you have questions, please don’t hesitate to reach out to the IR team. Have a great day.

Operator: Thank you again for participating in today’s conference call. You may now disconnect.